Medtronic PLC (MDT)
Return on equity (ROE)
Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Apr 26, 2024 | Jan 31, 2024 | Jan 26, 2024 | Oct 31, 2023 | Oct 27, 2023 | Jul 31, 2023 | Jul 28, 2023 | Apr 30, 2023 | Apr 28, 2023 | Jan 31, 2023 | Jan 27, 2023 | Oct 31, 2022 | Oct 28, 2022 | Jul 31, 2022 | Jul 29, 2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 4,663,000 | 4,260,000 | 3,620,000 | 3,672,000 | 3,952,000 | 4,207,000 | 4,462,000 | 3,931,000 | 3,400,000 | 3,670,000 | 3,940,000 | 4,371,000 | 4,802,000 | 4,050,000 | 3,298,000 | 3,005,000 | 2,712,000 | 3,770,000 | 4,828,000 | 5,379,000 |
Total stockholders’ equity | US$ in thousands | 48,024,000 | 49,387,000 | 48,494,000 | 47,947,000 | 50,214,000 | 50,214,000 | 51,792,000 | 51,792,000 | 51,460,000 | 51,460,000 | 51,178,000 | 51,178,000 | 51,483,000 | 51,483,000 | 51,441,000 | 51,441,000 | 51,880,000 | 51,880,000 | 52,672,000 | 52,672,000 |
ROE | 9.71% | 8.63% | 7.46% | 7.66% | 7.87% | 8.38% | 8.62% | 7.59% | 6.61% | 7.13% | 7.70% | 8.54% | 9.33% | 7.87% | 6.41% | 5.84% | 5.23% | 7.27% | 9.17% | 10.21% |
April 30, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $4,663,000K ÷ $48,024,000K
= 9.71%
The return on equity (ROE) for Medtronic PLC has exhibited some fluctuations over the reviewed periods. Starting at 10.21% in July 2022, the ROE showed a declining trend up to January 2023, reaching its lowest point of 5.23%. From there, the ROE gradually improved, with intermittent fluctuations, such as an increase in April 2023 to 9.33%. The ROE ranged between 6.41% to 8.62% from January 2023 to January 2024. The trend continued to fluctuate between 7.13% and 9.71% as of April 2025, indicating some volatility in Medtronic PLC's ability to generate profits from shareholders' equity. Overall, the ROE performance suggests that the company has been efficient in generating returns relative to its shareholders' investments, albeit with some variability in performance over the periods analyzed.
Peer comparison
Apr 30, 2025